G-protein receptor kinase 4 polymorphism and response to antihypertensive therapy

Clinical Chemistry

Volumn 60, Issue 12, 2014, Pages 1543-1548

  Muskalla, Anne M ^a   Suter, Paolo M ^a   Saur, Matthias ^a,b   Nowak, Albina ^a   Hersberger, Martin ^a,c   Krayenbuehl, Pierre Alexandre ^a,d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Rheumatology and Pain Center   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d Division of Internal Medicine   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR KINASE 4; INDAPAMIDE; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; GRK4 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; DRUG EFFICACY; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TOBACCO DEPENDENCE; TREATMENT RESPONSE; BLOOD PRESSURE; DRUG EFFECTS; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 84924518024     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.226605     Document Type: Article

References (27)

1. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013; 369:448-57.
2. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann of medicine 2002; 34:88-95.
3. Williams SM, Ritchie MD, Phillips JA 3rd, Dawson E, Prince M, Dzhura E, et al. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered 2004; 57:28-38.
4. Institute of Medicine (US) Committee on Strategies to Reduce Sodium Intake; Henney JE, Taylor CL, Boon CS, eds. Strategies to reduce sodium intake in the United States. Washington (DC): National Academies Press; 2010.
5. Weinberger MH Salt sensitivity of blood pressure in humans. Hypertension 1996; 27:481-90.
6. Rodriguez BL, Labarthe DR, Huang B, LopezGomez J. Rise of blood pressure with age. New evidence of population differences. Hypertension 1994; 24:779-85.
7. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991; 18: 67-71.
8. Reudelhuber TL Salt-sensitive hypertension: if only it were as simple as rocket science. J Clin Invest 2003; 111:1115-6.
9. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 1999; 33:1036-42.
10. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, et al. Role of the d1a dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996; 97:2283-8.
11. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacology & therapeutics 1998; 80:149-82.
12. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 1998; 32:187-97.
13. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 2002; 11: 87-92.
14. Shikuma R, Yoshimura M, Kambara S, Yamazaki H, Takashina R, Takahashi H, et al. Dopaminergic modulation of salt sensitivity in patients with essential hypertension. Life Sci 1986; 38:915-21.
15. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A 2002; 99: 3872-7.
16. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19:233-46.
17. Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, et al. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 2001; 38:773-8.
18. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, et al. Association of the alpha-adducin locus with essential hypertension. Hypertension 1995; 25:320-6.
19. Jose PA, Soares-da-Silva P, Eisner GM, Felder RA. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta 2010; 1802:1259-67.
20. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clinical chemistry 2006; 52:352-60.
21. Zhu H, Lu Y, Wang X, Treiber FA, Harshfield GA, Snieder H, Dong Y. The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am J Hypertens 2006; 19: 61-6.
22. Chantrel F, Moulin B, Hannedouche T. Blood pressure, diabetes and diabetic nephropathy. Diabetes Metab 2000:26(Suppl 4);37-44.
23. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276(23):1886-92
24. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-97.
25. Bhatnagar V, O'Connor DT, Brophy VH, Schork NJ, Richard E, Salem RM, et al. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens 2009; 22:332-8.
26. Vandell AG, Lobmeyer MT, Gawronski BE, Langaee TY, Gong Y, Gums JG, et al. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension 2012; 60 957-64.
27. Chen K, Fu C, Chen C, Liu L, Ren H, Han Y et al. Role of GRK4 in the regulation of arterial AT1 receptor in hypertension. Hypertension 2014; 63 289-96.